Management of Gynecologic Issues in Women With Breast Cancer
Publication Date: March 1, 2012
Last Updated: March 14, 2022
Recommendations and Conclusions
The following recommendation and conclusion is based on good and consistent scientific evidence.
SSRIs and SNRIs have both been shown to be safe and to reduce the severity of hot flushes in patients with breast cancer, although caution must be used when using these agents in conjunction with tamoxifen. Gabapentin and clonidine are other options for management of hot flushes.
574
Title
Management of Gynecologic Issues in Women With Breast Cancer
Authoring Organization
American College of Obstetricians and Gynecologists